BackAcelyrin Overview

Acelyrin Operating Income

Latest operating income for SLRN: $-290M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-59855000.00
↓ 27.69% YoY

As of Mar 31, 2025

Annual Operating Income (TTM)

$-293339000.00
↓ 9.74% YoY

Trailing 12 months ending Mar 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Acelyrin (SLRN) FAQ

As of the most recent data (March 2025), SLRN shows a operating income of $-290M. That compares with $-330M in the prior-year period — up 9.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLRN's operating income is now $-290M (was $-330M) — a 9.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Acelyrin is outperforming or lagging.

Tracking SLRN's operating income over time shows whether Acelyrin is scaling, shrinking, or reshaping that part of the business. The current reading is $-290M That compares with $-330M in the prior-year period — up 9.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Acelyrin's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-290M) with ownership activity and broader fundamentals.